These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 3986978)
41. Plasma apoproteins and the severity of coronary artery disease. Sedlis SP; Schechtman KB; Ludbrook PA; Sobel BE; Schonfeld G Circulation; 1986 May; 73(5):978-86. PubMed ID: 3084125 [TBL] [Abstract][Full Text] [Related]
42. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Boquist S; Ruotolo G; Tang R; Björkegren J; Bond MG; de Faire U; Karpe F; Hamsten A Circulation; 1999 Aug; 100(7):723-8. PubMed ID: 10449694 [TBL] [Abstract][Full Text] [Related]
43. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296 [TBL] [Abstract][Full Text] [Related]
44. Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Kwiterovich PO; Coresh J; Smith HH; Bachorik PS; Derby CA; Pearson TA Am J Cardiol; 1992 Apr; 69(12):1015-21. PubMed ID: 1561971 [TBL] [Abstract][Full Text] [Related]
45. Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations. Wang J; Freeman DJ; Grundy SM; Levine DM; Guerra R; Cohen JC J Clin Invest; 1998 Mar; 101(6):1283-91. PubMed ID: 9502769 [TBL] [Abstract][Full Text] [Related]
46. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease]. Breier C Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343 [TBL] [Abstract][Full Text] [Related]
47. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations. Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843 [TBL] [Abstract][Full Text] [Related]
48. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
49. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease. Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512 [TBL] [Abstract][Full Text] [Related]
52. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Godsland IF; Wynn V; Crook D; Miller NE Am Heart J; 1987 Dec; 114(6):1467-503. PubMed ID: 3318361 [TBL] [Abstract][Full Text] [Related]
53. Metabolic determinants of the course of coronary artery disease in men. Watts GF; Mandalia S; Slavin BM; Brunt JN; Coltart DJ; Lewis B Clin Chem; 1994 Dec; 40(12):2240-6. PubMed ID: 7988012 [TBL] [Abstract][Full Text] [Related]
54. Relationships between triglycerides, lipoproteins, glucose and coronary artery disease. Hobbs GA; Wagner SG; Levinson SS Clin Chim Acta; 1995 Jun; 238(1):59-70. PubMed ID: 7554296 [TBL] [Abstract][Full Text] [Related]
55. Vitamin E compared with other potential risk factor concentrations in patients with and without coronary artery disease: a case-matched study. Van Lente F; Daher R; Waletzky JA Eur J Clin Chem Clin Biochem; 1994 Aug; 32(8):583-7. PubMed ID: 7819429 [TBL] [Abstract][Full Text] [Related]
56. Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects. Syvänne M; Pajunen P; Kahri J; Lahdenperä S; Ehnholm C; Nieminen MS; Taskinen MR Coron Artery Dis; 2001 Mar; 12(2):99-106. PubMed ID: 11281308 [TBL] [Abstract][Full Text] [Related]
57. Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes. Steiner G; Tkác I; Uffelman KD; Lewis GF Atherosclerosis; 1998 Mar; 137(1):211-4. PubMed ID: 9568754 [TBL] [Abstract][Full Text] [Related]
58. Diagnostic value of immune cholesterol as a marker for atherosclerosis. Orekhov AN; Kalenich OS; Tertov VV; Perova NV; Novikov IyD ; Lyakishev AA; Deev AD; Ruda MYa J Cardiovasc Risk; 1995 Oct; 2(5):459-66. PubMed ID: 8749274 [TBL] [Abstract][Full Text] [Related]
59. Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Grundy SM Clin Chem; 1995 Jan; 41(1):139-46. PubMed ID: 7813068 [TBL] [Abstract][Full Text] [Related]
60. A comparison of blood lipid and lipoprotein values in young adults who die suddenly and unexpectedly from atherosclerotic coronary artery disease with other noncardiac deaths. Hiserodt JC; Perper JA; Koehler SA; Orchard TJ Am J Forensic Med Pathol; 1995 Jun; 16(2):101-6. PubMed ID: 7572860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]